State of the Art in Idiopathic Pulmonary Fibrosis

Elie El Agha; Malgorzata Wygrecka

doi:10.3390/cells11162487

State of the Art in Idiopathic Pulmonary Fibrosis

Cells. 2022 Aug 11;11(16):2487. doi: 10.3390/cells11162487.

Authors

Elie El Agha^{1

2

3

4}, Malgorzata Wygrecka^{1

3

4}

Affiliations

¹ Department of Medicine II, Internal Medicine, Pulmonary and Critical Care, Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig University Giessen, German Center for Lung Research (DZL), 35392 Giessen, Germany.
² Department of Medicine V, Internal Medicine, Infectious Diseases and Infection Control, Universities of Giessen and Marburg Lung Center (UGMLC), Justus-Liebig University Giessen, German Center for Lung Research (DZL), 35392 Giessen, Germany.
³ Cardio-Pulmonary Institute (CPI), Justus-Liebig University Giessen, 35392 Giessen, Germany.
⁴ Institute for Lung Health (ILH), Justus-Liebig University Giessen, 35392 Giessen, Germany.

Abstract

Idiopathic pulmonary fibrosis (IPF) is a form of usual interstitial pneumonia (UIP), though its origin is unknown [...].

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Idiopathic Pulmonary Fibrosis*
Tomography, X-Ray Computed

Grants and funding

E.E.A. acknowledges financial support from the Institute for Lung Health (ILH) and the German Research Foundation (DFG; KFO309 P7, SFB CRC 1213 268555672 project A04 and EL 931/4-1). M.W. acknowledges financial support from the DZL (82 DZL 005A1) and the Else Kröner-Fresenius Foundation (2014_A179).